Stage III Colorectal Cancer: Amanda's Survivor Story

Patient Info: Amanda Peters, Female, 40s | Stage III

Biomarkers: No genetic markers reported

As of September 2023, Amanda reported no recurrence about 3 years after Stage IIIB rectal cancer surgery and adjuvant chemotherapy, with surveillance CT scans now yearly.

The Patient StoryRead more →

Rare blood-vessel-based lung tumor (epithelioid hemangioendothelioma)

Patient Info: Anonymized, Female

Biomarkers: PEH positive for CD31, ERF and TFE3

At 1-year CT follow-up, residual pulmonary nodules were stable and there were no distant metastases.

PubMed CentralRead more →

Cancer Researcher Becomes Cancer Survivor

Patient Info: J. Mark Brown, Male | Stage III

Ten years after his Stage III colorectal cancer diagnosis, Mark described the treatment as having cured his cancer; he had completed 6 years of periodic oncology follow-up and was living actively with an ileostomy.

Cleveland ClinicRead more →

Stage IV Colorectal Cancer: Danielle's Patient Story

Patient Info: Danielle Archer, Female, 40s | Stage IV

Biomarkers: No genetic markers reported

Metastatic Site: Liver; lungs

As of August 2023, Danielle was living with Stage IV metastatic colon cancer involving liver and lung lesions that were stable on ongoing treatment and 3-month surveillance scans.

The Patient StoryRead more →

Kelly's Stage 3 Breast Cancer Story: “I’m Still Here & THRIVING!"

Patient Info: Kelly Thomas, Female, Under 40 | Stage III

Biomarkers: Initial triple-negative breast cancer; after surgery

As of August 2023, Kelly was 5 years from her Stage IIIC triple-negative breast cancer diagnosis with no recurrence reported.

The Patient StoryRead more →

HER2-Positive Breast Cancer: Susan's Survivor Story

Patient Info: Susan, Female, 70+

Biomarkers: 2021 breast cancer described as estrogen-positive and progesterone-positive; HER2 not reported. First breast cancer biomarker status not reported.

As of August 2023, Susan was living in survivorship after a first breast cancer treated with lumpectomy, chemotherapy, and radiation and a later separate breast cancer treated with bilateral mastectomy.

The Patient StoryRead more →

Stage I Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage I

Biomarkers: CD56-positive; neuroendocrine tumor

As of August 2023, Lauren reported no signs of more cancer after bronchoscopy and surgery removing the right lower and middle lung lobes, with surveillance extended to yearly CT scans.

The Patient StoryRead more →

Stage IV Breast Cancer: Britney's Patient Story

Patient Info: Britney Beadle, Female, Under 40 | Stage IV

Metastatic Site: Bone; liver; brain; lungs

As of August 2023, Britney was living with Stage IV breast cancer on Enhertu every 21 days, with liver clear and bone/lung disease showing regression on the latest described scan.

The Patient StoryRead more →

Stage III Colorectal Cancer: Kelly's Survivor Story

Patient Info: Kelly Spill, Female | Stage III

As of August 2023, Kelly was in complete clinical response/NED after 9 dostarlimab treatments over about 6 months, avoiding the initially expected chemoradiation and surgery path.

The Patient StoryRead more →

Stage I Triple-Negative Breast Cancer: Melissa's Survivor Story

Patient Info: Melissa Berry, Female, 40s | Stage I

Biomarkers: BRCA mutation reported; triple-negative breast cancer

As of July 2023, Melissa was a 10-year Stage I triple-negative breast cancer survivor with no recurrence reported.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Michelle's Patient Story

Patient Info: Michelle Cappel, Female, 40s | Stage IV

Metastatic Site: Leg/femoral nerve area

As of July 2023, Michelle was living with recurrent Stage IV colorectal cancer after prior NED, leg/femoral-nerve recurrence, radiation, surgery with clear margins, and ongoing surveillance.

The Patient StoryRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Megan's Survivor Story

Patient Info: Megan Claire Chase, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2 not reported

As of July 2023, Megan-Claire was in survivorship after Stage II invasive lobular breast cancer, with clear early scans but significant long-term effects, surgical menopause, chronic pain, fatigue, chemo brain, and inability to tolerate recurrence-prevention medications.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Michelle's Survivor Story

Patient Info: Michelle Cappel, Female, 40s | Stage IV

Biomarkers: Lynch syndrome negative; no hereditary genetic markers reported

Metastatic Site: Ovary

As of July 2023, Michelle had achieved no evidence of disease after FOLFOX chemotherapy and 12-hour surgery for Stage IV colorectal cancer with ovarian metastasis, while continuing to live with scan anxiety and surveillance.

The Patient StoryRead more →

Rectal cancer managed with active surveillance in a patient with inflammatory bowel disease

Patient Info: Anonymized, Female

No local recurrence or systemic disease was detected throughout surveillance, and she remained disease-free 9 years after rectal-cancer treatment.

PubMed CentralRead more →

Invasive Lobular Carcinoma: Lucinda's Patient Story

Patient Info: Lucinda Rudolph, Female, 60s

As of June 2023, Lucinda was living well after treatment for locally advanced recurrent invasive lobular breast cancer, taking exemestane, receiving supportive care for neuropathy, and returning to MD Anderson every 6 months for checkups.

MD AndersonRead more →

Cynthia: Stage II Breast Cancer

Patient Info: Cynthia, Female | Stage II

Cynthia completed surgery and 25 rounds of radiation for Stage IIB invasive ductal carcinoma and was about 4 years into survivorship with normal follow-up, ongoing physical effects, and breast cancer education advocacy.

The Patient StoryRead more →

My Colorectal Cancer Story: How I Changed My Diet After Cancer

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica was all-clear after 5 years following Stage III bowel cancer treatment and described survivorship changes in diet, exercise, rest, stress, and emotional healing.

The Patient StoryRead more →

Stage III Colorectal Cancer: Angelica's Survivor Story

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica had received her 5-year all-clear after Stage III bowel cancer treatment; later colonoscopy surveillance was reassuring and a liver cyst had disappeared.

The Patient StoryRead more →

Metastatic breast cancer with a blood condition that mimicked multiple myeloma

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Oestrogen receptor-positive

Metastatic Site: bone

Her pain came under control and the metastatic breast cancer remained stable for approximately 5 years. MGUS did not progress to myeloma, and she later died from causes unrelated to cancer.

PubMed CentralRead more →

Stage I Lung Cancer: Terri's Survivor Story

Patient Info: Terri Ann DiJulio, Female, 40s | Stage I

Biomarkers: Not reported for patient; family history of lung cancer noted

As of June 2023, Terri Ann was considered no evidence of disease after 3 early-stage lung cancer diagnoses treated with surgery and SBRT, and she had returned to 6-month follow-up while continuing advocacy and cycling.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Bart's Survivor Story

Patient Info: Bart Wilson, Male, Under 40 | Stage IV

Metastatic Site: Liver

As of May 2023, Bart had shown no evidence of disease for almost 3 years after surgery, FOLFOX, portal vein embolization, extended right hepatectomy, and adjuvant capecitabine for Stage IV colon cancer with liver metastases.

MD AndersonRead more →

Lung cancer recurrence in the thyroid, initially mistaken for thyroid cancer

Patient Info: Anonymized, Male | Stage IV

Biomarkers: EGFR exon 19 deletion; TTF-1-positive; Napsin A-positive; PAX8-negative; thyroglobulin staining limited to tumour cells adjacent to normal thyroid tissue

Metastatic Site: thyroid; cervical lymph nodes

After starting osimertinib for EGFR exon 19-deleted recurrent lung adenocarcinoma, he was disease free 5 months after thyroid surgery.

PubMed CentralRead more →

Stage II Colorectal Cancer: Amanda's Survivor Story

Patient Info: Amanda, Female, Under 40 | Stage II

Biomarkers: Genetic mutations involving colon, kidney, and skin cancer risk were reported; specific genes were not named

As of May 2023, Amanda had completed surgery and chemotherapy for Stage IIA sigmoid colon cancer and was in close surveillance, with CT scans every 6 months, bloodwork every 3 months, colonoscopy follow-up, and normal cancer-marker bloodwork.

The Patient StoryRead more →

Rare lung sarcoma causing repeated collapsed lungs

Patient Info: Anonymized, Female | Stage I

Biomarkers: SS18-SSX2 fusion; CD99-positive; epithelial membrane antigen-positive; TLE1-positive; BCL-2-positive

She remained well under surveillance, with no evidence of disease on imaging at 3 years after definitive lobectomy.

PubMed CentralRead more →